Clinigen Group PLC

Clinigen Group PLC
Stock Exchange Other OTC
EPS
$0.27
Market Cap
-
Shares Outstanding
115.37 M
Public Float
-
Clinigen Group PLC
Stock Exchange London Stock Exchange
EPS
GBP20.07
Market Cap
GBP1.3 B
Shares Outstanding
132.48 M
Public Float
119.37 M

Profile

Address
Pitcairn House
Burton-on-Trent Staffordshire DE14 2WW
United Kingdom
Employees -
Website http://clinigen.co.uk
Updated 07/08/2019
Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA), Clinigen Specialty Pharmaceuticals (SP), and Link Health Care. The Clinigen CTS segment sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies.

Financials

View All

Shaun Edward Chilton
Executive Director & Group Deputy CEO
Martin Abell
Chief Financial Officer & Executive Director